Why the study?
Can inflammatory markers predict restenosis and post-procedural coronary events in patients undergoing coronary angioplasty?
Can inflammatory markers predict restenosis and post-procedural coronary events in patients undergoing coronary angioplasty?
Answers are grounded in this paper and cite their sources.
Inflammatory markers may have potential utility in predicting restenosis and post-procedural coronary events in patients undergoing coronary interventions.
Abundant data links inflammatory mechanisms to atheromatous plaque destabilization leading to plaque rupture and coronary events. The discovery of inflammatory cells and inflammatory mediators within atherosclerotic plaques prone to rupture led to a series of studies demonstrating an association between various markers of inflammation and future coronary events. Inflammatory markers have also been used in patients undergoing coronary angioplasty in an attempt to predict restenosis and risk for post-procedural coronary events. This review article provides an overview on the potential use of inflammatory markers in the context of coronary interventions.
No takes yet. Share an insight, caveat, or question.
Doron Aronson (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: